Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
Leonard G. Presta, H Chen, Shane J. O'Connor et al. · PubMed · 1997
Vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis associated with tumors and other pathological conditions, including proliferative diabetic retinopathy and age-related macular degeneration. The murine anti-human VEGF monoclonal antibody (muMAb VEGF) A.4.6.1 has been shown to potently suppress angiogenesis and growth in a variety of human tumor cells lines transplanted in nude mice and also to inhibit neovascularization in a primate model of ischemic retinal disease. In this report, we describe the humanization of muMAb VEGF A.4.6.1. by site-directed mutagenesis of a human framework. Not only the residues involved in the six complementarity-determining regions but also several framework residues were changed from human to murine. Humanized anti-VEGF F(ab) and IgG1 variants bind VEGF with affinity very similar to that of the original murine antibody. Furthermore, recombinant humanized MAb VEGF inhibits VEGF-induced proliferation of endothelial cells in vitro and tumor growth in vivo with potency and efficacy very similar to those of muMAb VEGF A.4.6.1. Therefore, recombinant humanized MAb VEGF is suitable to test the hypothesis that inhibition of VEGF-induced angiogenesis is a valid strategy for the treatment of solid tumors and other disorders in humans.
Cited by 1,604 works.
Authors
- Leonard G. Presta
- H Chen
- Shane J. O'Connor
- Vanessa Chisholm
- Y. Gloria Meng
- LYNNE A. KRUMMEN
- Napoleone Ferrara
References
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
- Sequences of proteins of immunological interest
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
- The Biology of Vascular Endothelial Growth Factor
- Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth